Blood
Composition of Blood, Plasma, and Hematopoiesis
1.5 hMonday, Mar 8, Week 17
Outcomes
- 1Describe the components of whole blood, plasma and formed elements and calculate hematocrit and plasma fraction from a centrifuged tube.
- 2Classify plasma proteins by origin and function, including albumin, globulins, fibrinogen and their contribution to oncotic pressure.
- 3Give the reference values for blood volume, pH, viscosity and osmolality and explain what changes each spot-check.
- 4Trace hematopoiesis from the hematopoietic stem cell through myeloid and lymphoid progenitors to each mature cell line.
- 5Name the sites of blood cell formation across fetal life, childhood and adulthood and the cytokines that drive each lineage.
- 6Recognize bone marrow cell lineages and red versus yellow marrow on marrow smears and sections.
Outline
- A
Composition and physical properties
- Whole blood is about 55 percent plasma, 45 percent cells (mostly RBCs), a buffy coat of WBCs and platelets under 1 percent spot-check.
- Hematocrit about 41-50 percent in men and 36-44 percent in women spot-check; low in anemia, high in polycythemia and dehydration.
- Total blood volume roughly 5 L (about 7-8 percent of body mass, 70-80 mL/kg) spot-check; pH 7.35-7.45; viscosity about 3-4 times water, mostly from RBCs; mildly warmer than core temperature.
- Serum is plasma without clotting factors, i.e. what remains after clot formation.
- Whole blood is a non-Newtonian fluid; higher hematocrit raises viscosity and resistance to flow.
- B
Plasma
- Plasma is about 92 percent water with proteins (6-8 g/dL total) spot-check, electrolytes (Na+ the dominant cation), nutrients, wastes, gases and hormones.
- Albumin (about 60 percent of protein; made by the liver) supplies most oncotic pressure and carries fatty acids, bilirubin, drugs and hormones spot-check.
- Globulins: alpha and beta (transport, e.g. transferrin, ceruloplasmin, lipoproteins, complement) and gamma (immunoglobulins made by plasma cells).
- Fibrinogen (factor I, about 4 percent) converts to fibrin; its loss defines serum.
- Hypoalbuminemia (liver disease, nephrotic syndrome, malnutrition) lowers oncotic pressure and causes edema.
- Plasma oncotic pressure about 25 mm Hg opposes capillary filtration spot-check.
- C
Hematopoietic hierarchy and growth factors
- Pluripotent hematopoietic stem cells (CD34+) self-renew and differentiate into common myeloid progenitors (CMP) and common lymphoid progenitors (CLP).
- CMP gives megakaryocyte-erythroid progenitors (to RBCs and platelets) and granulocyte-monocyte progenitors (neutrophils, eosinophils, basophils, monocytes); CLP gives T, B and NK cells.
- Key cytokines: stem cell factor and IL-3 (multilineage), erythropoietin (RBC), thrombopoietin (platelets), G-CSF (neutrophils), GM-CSF, M-CSF (monocytes), IL-5 (eosinophils), IL-7 (lymphoid).
- Bone marrow stromal niche (fibroblasts, endothelium, osteoblasts, macrophages) supplies SCF, CXCL12 and adhesion.
- Clinical use: G-CSF mobilizes stem cells for bone marrow or cord-blood transplantation; CD34 counts guide collection.
- D
Sites and structure of marrow
- Yolk sac (weeks 3-8), then liver and spleen (months 2-7), then marrow takes over from the fifth month onward.
- Newborn marrow is red throughout; in adults hematopoiesis is limited to the axial skeleton, proximal femur and humerus.
- Yellow (fatty) marrow occupies long bone shafts and can revert to red marrow in severe demand.
- Marrow sinusoids have fenestrated endothelium; megakaryocytes extend proplatelets into the lumen; mature cells cross by transmigration.
- Marrow trephine (iliac crest) and aspirate are the diagnostic samples.
Lab
- Draw the hematopoietic tree with cytokines at each branch point and cover it to retest.
- Histology Guide MH-034bhr: sequence erythroid (proerythroblast to orthochromatic normoblast) and granulocytic (myeloblast to band) maturation stages in the marrow smear.
- Identify megakaryocytes, adipocytes and sinusoids on MH-034a and MHS-304.
- Work three hematocrit problems from centrifuged tube heights, and compute plasma volume from hematocrit and total blood volume.
Erythrocytes, Hemoglobin, Iron, and Erythropoiesis
1.5 hTuesday, Mar 9, Week 17
Outcomes
- 7Describe the biconcave RBC shape, membrane cytoskeleton and anucleate metabolism and explain how they support gas transport and deformability.
- 8Explain the structure of adult, fetal and variant hemoglobin, including heme, globin chains and the cooperative binding that shapes the oxyhemoglobin dissociation curve.
- 9Describe regulation of erythropoietin by renal hypoxia through HIF and predict its response to altitude, anemia and renal failure.
- 10Trace dietary iron absorption, transport, storage and recycling, including hepcidin.
- 11Explain the roles of vitamin B12 and folate in DNA synthesis and the absorption of B12 requiring intrinsic factor.
- 12Classify anemias by MCV and mechanism and interpret hemoglobin, MCV, reticulocyte count and iron studies.
- 13Trace RBC senescence and heme catabolism to unconjugated bilirubin and describe jaundice types.
Outline
- A
RBC structure and metabolism
- 7-8 micrometre biconcave anucleate discs with surface-to-volume ratio supporting deformation through 3-micrometre capillaries and splenic cords.
- Cytoskeleton of spectrin, ankyrin, band 3 and protein 4.1 anchors the membrane; defects give hereditary spherocytosis (ankyrin/spectrin) and elliptocytosis.
- No mitochondria: glycolysis supplies ATP; the pentose phosphate pathway makes NADPH for glutathione, so G6PD deficiency gives oxidant hemolysis with Heinz bodies.
- Carbonic anhydrase and band 3 chloride-bicarbonate exchange carry most CO2 as HCO3-.
- Lifespan about 120 days spot-check; counts about 4.5-5.9 x10^12/L men and 4.0-5.2 x10^12/L women spot-check.
- B
Hemoglobin structure and variants
- HbA is a tetramer (alpha2 beta2) with four heme groups, each with Fe2+ binding one O2; T (tense) to R (relaxed) transition produces the sigmoid curve.
- HbA2 (alpha2 delta2) under 3.5 percent and HbF (alpha2 gamma2) about 1 percent in adults; HbF binds 2,3-BPG poorly and has higher O2 affinity, supporting placental transfer spot-check.
- Right shift (lower affinity) with high CO2, H+ (Bohr effect), temperature and 2,3-BPG; left shift with the opposite, and with CO and HbF.
- Sickle cell disease: Glu6Val in beta globin, HbS polymerizes when deoxygenated, causing sickling, vaso-occlusion and hemolysis; heterozygotes (trait) have malaria resistance.
- Thalassemias: reduced alpha or beta chain synthesis gives microcytic anemia with unbalanced chains; methemoglobin has Fe3+ and cannot carry O2.
- Heme synthesis (ALA synthase, vitamin B6, lead inhibits ALA dehydratase and ferrochelatase) in mitochondria and cytoplasm.
- C
Erythropoiesis and erythropoietin
- Sequence: proerythroblast, basophilic, polychromatic and orthochromatic erythroblast, enucleation, reticulocyte (1-2 percent of RBCs in blood, polychromatic with residual RNA), mature RBC spot-check.
- EPO is made by peritubular interstitial fibroblast-like cells in the renal cortex (liver in fetus) in response to low tissue O2.
- Under normoxia prolyl hydroxylase tags HIF-alpha for VHL-mediated degradation; hypoxia stabilizes HIF, which raises EPO transcription.
- EPO acts on CFU-E and proerythroblasts through the EPO receptor-JAK2-STAT5 pathway to prevent apoptosis.
- Anemia of chronic kidney disease responds to recombinant EPO; polycythemia vera has JAK2 V617F with low EPO; EPO abuse is a doping concern.
- D
Iron, B12 and folate
- Body iron about 3-4 g, mostly in hemoglobin; heme iron is absorbed better than non-heme iron; duodenal DMT1 takes up Fe2+ (after DcytB reduction), ferroportin exports it.
- Transport on transferrin; storage as ferritin (and hemosiderin); transferrin receptor 1 delivers iron to erythroblasts.
- Hepcidin from the liver blocks ferroportin; rises with inflammation (anemia of chronic disease) and falls in iron deficiency.
- Iron deficiency: low ferritin, high TIBC, microcytic hypochromic cells; iron overload (hemochromatosis) shows high ferritin and transferrin saturation.
- B12 requires intrinsic factor from gastric parietal cells and is absorbed in the terminal ileum; stores last years; deficiency also causes subacute combined degeneration of the spinal cord.
- Folate absorption occurs in the jejunum; stores last months; both deficiencies impair thymidylate synthesis and give megaloblastic anemia with hypersegmented neutrophils.
- Elevated methylmalonic acid separates B12 from folate deficiency.
- E
Anemia classification and RBC destruction
- Microcytic (MCV under 80 fL): iron deficiency, thalassemia, anemia of chronic disease, sideroblastic; normocytic: acute blood loss, hemolysis, renal disease; macrocytic (over 100 fL): B12/folate deficiency, liver disease, alcohol spot-check.
- Aplastic anemia is pancytopenia with hypocellular marrow.
- Macrophages in spleen and liver phagocytose aged RBCs; heme to biliverdin to unconjugated bilirubin (albumin-bound) to liver conjugation to bile and urobilinogen.
- Hemolysis raises indirect bilirubin, LDH and reticulocytes and lowers haptoglobin; neonatal jaundice follows from immature conjugation.
Lab
- Histology Guide MH-033: find erythrocytes, estimate the central pallor ratio and compare size with a small lymphocyte nucleus.
- Histology Guide MH-033hr: identify a reticulocyte or polychromatic RBC if present and note anisocytosis.
- Sketch an oxyhemoglobin dissociation curve showing right and left shifts and HbF, annotating P50.
- Interpret four case panels (Hb, MCV, reticulocytes, ferritin, TIBC, B12) and name the anemia.
- Make a flow diagram of iron from gut to marrow to macrophage and back, marking hepcidin.
Leukocytes and Platelets
1.5 hWednesday, Mar 10, Week 17
Outcomes
- 14Identify the five leukocyte types on a Wright-stained smear using size, nuclear shape, chromatin and granule color.
- 15Give the reference differential and absolute counts for each leukocyte type and state the causes of common shifts spot-check.
- 16Describe the neutrophil, monocyte, eosinophil and basophil responses to infection and allergic disease at overview level.
- 17Trace platelet formation from megakaryocyte under thrombopoietin and describe the platelet granules and membrane features.
- 18Interpret leukocytosis, leukopenia, thrombocytopenia and thrombocytosis and the left shift.
Outline
- A
Granulocytes on smear
- Neutrophil (50-70 percent; 12-15 micrometres): 3-5 lobed nucleus, pale pink fine granules; bands have a U-shaped nucleus; females may show a drumstick (Barr body).
- Eosinophil (1-4 percent): bilobed nucleus with large bright red-orange granules; rise in parasites, allergy, drug reaction.
- Basophil (under 1 percent): lobed nucleus obscured by large dark purple granules containing histamine and heparin; rise in myeloproliferative disease.
- Left shift is increased bands and immature forms in infection; hypersegmentation (over 5 lobes) suggests megaloblastic anemia.
- Neutrophil lifespan hours in blood, days in tissue; marginating pool equals circulating pool; stress, steroids and epinephrine demarginate cells.
- B
Agranulocytes on smear
- Lymphocyte (20-40 percent): round dark nucleus occupying most of a small cell with thin blue cytoplasm; large granular lymphocytes are NK cells.
- Monocyte (2-8 percent; largest, 15-20 micrometres): indented kidney or horseshoe nucleus, gray-blue cytoplasm with fine vacuoles; becomes tissue macrophage.
- Reactive (atypical) lymphocytes in infectious mononucleosis are large with abundant cytoplasm.
- Normal total WBC 4-11 x10^9/L spot-check; identify by counting 100 cells in a differential and multiplying by total count for absolute values.
- Mnemonic order by abundance: neutrophils, lymphocytes, monocytes, eosinophils, basophils.
- C
Leukocyte functions (overview)
- Neutrophils: diapedesis, chemotaxis, phagocytosis and respiratory burst (NADPH oxidase; deficient in chronic granulomatous disease).
- Eosinophils: anti-parasitic and modulate allergy; basophils and mast cells: IgE-triggered histamine release.
- Monocytes and macrophages: phagocytosis and antigen presentation; lymphocyte function is covered in chapter 26.
- Leukopenia and neutropenia (under 1.5 x10^9/L) increase infection risk; leukemias show uncontrolled proliferation of a lineage.
- D
Platelets
- Fragments of megakaryocyte cytoplasm, 2-3 micrometres, anucleate, lifespan 7-10 days, count 150-400 x10^9/L spot-check.
- Thrombopoietin (liver) binds platelet and megakaryocyte c-Mpl receptors and is cleared by them; megakaryocytes are polyploid and shed proplatelets in marrow sinusoids; about one-third of platelets are splenic.
- Structure: glycocalyx with GPIb and GPIIb/IIIa, open canalicular system, dense tubular system, alpha granules (vWF, fibrinogen, PDGF) and dense granules (ADP, ATP, serotonin, Ca2+).
- Smear appearance: small purple granular clusters; use them to estimate count.
- Thrombocytopenia (under 150 x10^9/L; bleeding often when under 50, spontaneous under 10-20) from ITP, TTP, DIC, heparin-induced thrombocytopenia or marrow failure.
Lab
- Histology Guide MH-033hr: identify each leukocyte type on the blood smear and name the single feature that separates it from its look-alike.
- R&P plates 16 and 17: label neutrophil, eosinophil, basophil, lymphocyte, monocyte and platelet.
- Perform a 100-cell differential on a smear image set, convert to absolute counts for a given WBC, and decide which values are abnormal.
- Compare a neutrophil band and a monocyte side by side and write the three distinguishing criteria.
Hemostasis and Coagulation
2 hThursday, Mar 11, Week 17
Outcomes
- 19Sequence vascular spasm, platelet plug formation (adhesion, activation, aggregation) and coagulation in a bleeding injury.
- 20Diagram the intrinsic, extrinsic and common coagulation pathways with factors, cofactors, calcium and phospholipid surface.
- 21Explain the cell-based model of coagulation as initiation, amplification and propagation on cell surfaces.
- 22Interpret PT/INR, aPTT, thrombin time, platelet count and fibrinogen results and predict which factors or drugs they reflect.
- 23Describe the roles of vitamin K, thrombin, factor XIII and fibrin in clot formation and the vitamin K dependent factors.
- 24Explain the anticoagulant and fibrinolytic systems: antithrombin, protein C/S, TFPI, plasmin, tPA and PAI-1.
- 25Relate hemophilia A and B, von Willebrand disease, DIC, thrombosis and anticoagulant drugs to specific steps of hemostasis.
Outline
- A
Primary hemostasis
- Vascular spasm: smooth muscle contraction from local myogenic response, endothelin and thromboxane A2, lasting minutes.
- Adhesion: exposed collagen binds von Willebrand factor, which captures platelets via GPIb.
- Activation: platelets change shape, release ADP and serotonin (dense granules) and make thromboxane A2 (COX-1; blocked by aspirin).
- Aggregation: GPIIb/IIIa binds fibrinogen bridges; clopidogrel blocks the P2Y12 ADP receptor, abciximab blocks IIb/IIIa.
- Intact endothelium resists clotting with NO, prostacyclin and thrombomodulin; defects in primary hemostasis give mucocutaneous bleeding and petechiae.
- Bernard-Soulier is GPIb deficiency; Glanzmann is IIb/IIIa deficiency; von Willebrand disease is the commonest inherited bleeding disorder.
- B
Coagulation cascade
- Extrinsic pathway: tissue factor (III) plus VIIa, Ca2+ (IV), activates X; measured by PT.
- Intrinsic pathway: contact activation by XII, then XI, IX (with VIIIa), activates X on phospholipid; measured by aPTT.
- Common pathway: Xa with Va, Ca2+ and phospholipid (prothrombinase) converts prothrombin (II) to thrombin (IIa); thrombin converts fibrinogen (I) to fibrin and activates V, VIII, XI and XIII.
- Factor XIIIa cross-links fibrin to stabilize the clot; platelets retract the clot via actin/myosin.
- Cell-based model: tissue factor on fibroblasts initiates a small thrombin burst, which activates platelets and cofactors (amplification), then tenase and prothrombinase on platelets drive a large thrombin burst (propagation).
- In vivo, the extrinsic path is the physiologic trigger; the intrinsic path amplifies, which explains why XII deficiency does not cause bleeding.
- C
Vitamin K and coagulation tests
- Vitamin K allows gamma-carboxylation of glutamate in factors II, VII, IX, X and proteins C and S, which is needed for Ca2+ and phospholipid binding.
- Warfarin blocks vitamin K epoxide reductase (VKORC1); factor VII has the shortest half-life, so PT prolongs first and early warfarin causes transient protein C deficiency (skin necrosis).
- PT (extrinsic and common: VII, X, V, II, I) reported as INR; aPTT (intrinsic and common: XII, XI, IX, VIII, X, V, II, I), monitors unfractionated heparin.
- Prolonged aPTT with normal PT: hemophilia A (VIII), hemophilia B (IX), XI, heparin; prolonged PT with normal aPTT: factor VII deficiency, early warfarin.
- A mixing study corrects a factor deficiency but not an inhibitor (lupus anticoagulant, factor antibody).
- Hemophilia A and B are X-linked recessive; hemarthrosis is typical; normal bleeding time and PT.
- Reference PT about 11-13.5 s, aPTT about 25-35 s spot-check; therapeutic INR commonly 2-3.
- D
Natural anticoagulants
- Antithrombin neutralizes thrombin and Xa, accelerated about 1000-fold by heparin; low-molecular-weight heparin mainly acts on Xa.
- Protein C (activated by thrombin-thrombomodulin) with protein S inactivates Va and VIIIa; factor V Leiden resists this and is the commonest inherited thrombophilia.
- Tissue factor pathway inhibitor (TFPI) blocks VIIa-TF-Xa; endothelium also makes NO, prostacyclin and heparan sulfate.
- Direct oral anticoagulants inhibit Xa (rivaroxaban, apixaban) or thrombin (dabigatran).
- E
Fibrinolysis
- tPA and urokinase convert plasminogen bound to fibrin into plasmin, which digests fibrin into fragments including D-dimer.
- Inhibitors: PAI-1 against tPA and alpha-2 antiplasmin against plasmin.
- Therapeutic tPA (alteplase) or streptokinase is used in stroke, MI and pulmonary embolism; tranexamic acid inhibits fibrinolysis.
- Elevated D-dimer indicates fibrin turnover and is a screening test (high negative predictive value) for venous thromboembolism.
- F
Pathology of hemostasis
- Virchow triad: stasis, endothelial injury and hypercoagulability drive thrombosis; deep vein thrombosis can embolize to the lung.
- DIC: widespread activation consumes platelets and fibrinogen, giving prolonged PT/aPTT, low platelets and high D-dimer.
- Liver disease impairs synthesis of most factors (except VIII), prolonging PT; vitamin K deficiency occurs in malabsorption and newborns.
- Heparin-induced thrombocytopenia is paradoxically prothrombotic due to anti-PF4/heparin antibodies.
Lab
- Draw the cascade with Roman-numeral factors, label which arm PT and aPTT measure, and mark where warfarin, heparin and DOACs act.
- Interpret a set of six coagulation panels (PT, aPTT, platelets, fibrinogen, D-dimer) for diagnoses such as hemophilia A, early warfarin, DIC, ITP and von Willebrand disease.
- Sequence the platelet plug steps from injury to stable clot as a labelled storyboard.
- Histology Guide MH-033hr: locate platelets on the smear and describe the clumping pattern.
Blood Groups and Transfusion
1 hFriday, Mar 12, Week 17
Outcomes
- 26Explain the ABO antigens, their biochemical basis in the H antigen and the naturally occurring antibodies.
- 27Predict the possible offspring phenotypes of an ABO and Rh cross using the genotypes.
- 28Compare the Rh system antigens with ABO antibodies by immunoglobulin class and clinical significance.
- 29Determine donor-recipient compatibility for red cells and plasma and describe the steps of the crossmatch.
- 30Explain hemolytic disease of the fetus and newborn and the role of anti-D prophylaxis.
- 31Describe the acute and delayed hemolytic and non-hemolytic transfusion reactions and the initial management.
Outline
- A
ABO system
- Antigens are carbohydrates on the RBC membrane built on the H antigen by glycosyltransferases from the ABO gene (chromosome 9): A adds N-acetylgalactosamine, B adds galactose, O is an inactive enzyme.
- A and B alleles are codominant; O is recessive; genotypes AA/AO give group A, BB/BO group B, AB group AB, OO group O.
- Naturally occurring IgM antibodies against the missing antigens develop in infancy through exposure to gut bacteria.
- Group O has anti-A and anti-B (universal red cell donor) and AB has neither (universal red cell recipient, universal plasma donor); O blood has H antigen only.
- Bombay phenotype lacks H antigen and so types as O but cannot receive O blood spot-check.
- Frequencies in the US: O about 45 percent, A about 40 percent, B about 11 percent, AB about 4 percent spot-check.
- B
Rh system
- Rh is multi-antigen; D antigen is the clinically dominant protein (RHD gene); D-positive about 85 percent of white populations spot-check.
- Anti-D forms only after exposure (transfusion, pregnancy); it is IgG and crosses the placenta, unlike ABO IgM.
- Genetics: D is dominant; Rh-negative is homozygous recessive (dd).
- A first sensitizing pregnancy is generally unaffected; later Rh-positive fetuses are at risk.
- C
Transfusion practice
- Type and screen: ABO/Rh typing by forward (cells) and reverse (serum) agglutination and antibody screen by indirect Coombs test.
- Crossmatch: mixing donor red cells with recipient serum to detect incompatibility; immediate-spin for ABO, antiglobulin phase for IgG antibodies.
- Choose red cells compatible with recipient plasma antibodies (O cells to anyone) and plasma compatible with recipient cells (AB plasma to anyone); Rh-negative females of child-bearing potential receive D-negative products.
- Acute hemolytic reaction (ABO mismatch): intravascular hemolysis with fever, hypotension, flank pain, hemoglobinuria, DIC; stop transfusion and check labeling.
- Febrile non-hemolytic (leukocyte cytokines), allergic/anaphylactic (IgA deficiency), TRALI (donor anti-HLA antibodies) and TACO (volume overload) are other reactions.
- Direct Coombs test detects antibody on patient RBCs (HDFN, autoimmune hemolysis).
- D
Hemolytic disease of the fetus and newborn
- Mechanism: Rh-negative mother sensitized by fetomaternal hemorrhage (at delivery, miscarriage or amniocentesis) makes IgG anti-D that crosses the placenta in later D-positive pregnancies.
- Fetal findings: hemolytic anemia, hydrops fetalis, extramedullary hematopoiesis (hepatosplenomegaly), neonatal hyperbilirubinemia and kernicterus.
- Prevention: anti-D immune globulin (RhoGAM) at 28 weeks and within 72 h after delivery of a D-positive baby, with extra dose guided by Kleihauer-Betke test or flow cytometry spot-check.
- ABO incompatibility (mother O, baby A or B) is more common but usually milder, and can affect a first pregnancy.
- Monitoring uses maternal antibody titers and middle cerebral artery Doppler; treatment includes intrauterine transfusion.
Lab
- Draw an agglutination grid for forward and reverse typing of the four ABO groups with Rh positive and negative.
- Work four Punnett squares for ABO and Rh parent crosses and list possible offspring phenotypes.
- Complete a crossmatch decision table for eight donor-recipient pairs, marking red-cell and plasma compatibility.
- Walk through a case of an Rh-negative mother with a second Rh-positive pregnancy and map prophylaxis timing.
Teach-back prompts
- Follow one hematopoietic stem cell to a mature RBC, naming the cytokine, the oxygen-sensing mechanism that controls it and the nutrients that cell line needs.
- Identify the five leukocytes and the platelet on a smear by describing, aloud, the distinguishing features of each.
- Walk through hemostasis from endothelial injury to a stabilized clot, and explain what PT and aPTT each measure and which drug or disease changes them.
- Explain ABO and Rh genetics and how a second pregnancy with an Rh-positive fetus can produce hemolytic disease, and how it is prevented.
Practical targets
- Erythrocyte on peripheral smear (Histology Guide MH-033)
- Neutrophil (R&P plate 17)
- Eosinophil (R&P plate 17)
- Basophil (R&P plate 17)
- Lymphocyte (R&P plate 16)
- Monocyte (R&P plate 16)
- Platelets on smear (Histology Guide MH-033hr)
- Megakaryocyte in bone marrow (Histology Guide MH-034bhr)
- Erythroblast stages in marrow smear (Histology Guide MH-034a)
- Granulocyte precursors (myelocyte, metamyelocyte, band) in marrow (Histology Guide MH-034bhr)
- Adipocytes and sinusoids in marrow section (Histology Guide MHS-304)
- Composition of blood diagram (NET plate BP15)